ライフサイエンスコーパス: phospho-specific antibody

1 terminal kinase (JNK) (by Western blots with phospho-specific antibodies).

2 also activated by TNF-alpha (as assessed by phospho-specific antibodies).

3 luorescence using the commercially available phospho-specific antibody.

4 omeric 14-3-3 form are not recognized by the phospho-specific antibody.

5 was evaluated by Western blot analysis using phospho-specific antibodies.

6 heir phosphorylation state was assessed with phospho-specific antibodies.

7 , were investigated by using newly developed phospho-specific antibodies.

8 (MAPK) activity increased, as determined by phospho-specific antibodies.

9 ssential to S6K regulation, as determined by phospho-specific antibodies.

10 ier data by non-radioactive approaches using phospho-specific antibodies.

11 mass spectrometry and Western blotting with phospho-specific antibodies.

12 the phosphorylation of Amots detected by the phospho-specific antibodies.

13 rylation was verified by immunoblotting with phospho-specific antibodies.

14 al-regulated kinase (ERK) was assessed using phospho-specific antibodies.

15 in high-throughput format without the use of phospho-specific antibodies.

16 e analyzed by immunoblotting with a panel of phospho-specific antibodies.

17 xO1 (but not FoxO1-AAA) was detectable using phospho-specific antibodies.

18 nse to non-androgen ligand stimulation using phospho-specific antibodies.

19 nd VE-cadherin was assessed by blotting with phospho-specific antibodies.

20 e of residues, as detected by a set of novel phospho-specific antibodies.

21 the cotransporter which can be detected with phospho-specific antibodies.

22 Site- and phospho-specific antibodies against a phosphorylated S15

23 eened for potential ATM/ATR substrates using phospho-specific antibodies against known ATM/ATR substr

24 Anti-phospho-specific antibodies against Ser(308) of BRCA1 de

25 e lysed in RIPA buffer for Western blot with phospho-specific antibodies against Smad2, JNK1/2, ERK1/

26 Phospho-specific antibodies against two of these sites r

27 In addition, using a phospho-specific antibody against IRS-1 phosphorylated a

28 Data obtained with a phospho-specific antibody against serine 216 suggest tha

29 Western blots using a novel phospho-specific antibody against this site suggest that

30 Using a phospho-specific antibody against threonine 68, we demon

31 Phospho-specific antibody analyses show that Thr-1136 ph

32 Here, we used phospho-specific antibodies and protein mass spectrometr

33 activity are limited as they rely heavily on phospho-specific antibodies and radioactive tags.

34 phorylation status of the MOP receptor using phospho-specific antibody and mass spectrometry.

35 ergy transfer biosensor, immunostaining with phospho-specific antibodies, and GST pull-down assays sh

36 ization, targeted FRET-based PKA biosensors, phospho-specific antibodies, and in vivo phosphorylation

37 By using a solid-phase kinase assay, a phospho-specific antibody, and extracts prepared from a

38 Using a phospho-specific antibody (anti-phospho-NKCC1 antibody R

39 supported by next-generation sequencing and phospho-specific-antibody array analysis.

40 This knowledge enabled the development of a phospho-specific antibody as a tool to monitor CHK-2 act

41 Here, we develop a phospho-specific antibody-based biosensor to detect acti

42 Probing with phospho-specific antibodies confirmed activation of FAK/

43 Immunoblotting with phospho-specific antibodies confirmed cAMP/vasopressin-d

44 osphopeptide mapping and immunoblotting with phospho-specific antibodies confirmed that Thr598 and Se

45 Finally, the use of a phospho-specific antibody demonstrates that endogenous D

46 Using a phospho-specific antibody developed against a degenerate

47 adaptations in titin splicing, whereas novel phospho-specific antibodies did not detect changes in ti

48 ctivity of mTOR in cytomegalic neurons using phospho-specific antibodies directed against known mTOR

49 phorylation at this site, or introduction of phospho-specific antibodies directed against this site,

50 tion of Cav-2, we have now generated a novel phospho-specific antibody directed against phospho-Cav-2

51 uantitative Western analysis using total and phospho-specific antibodies for PI3K, Akt, and p70(s6k).

52 Analysis using phospho-specific antibodies for the IR revealed preferen

53 ids the conventional paradigm of requiring a phospho-specific antibody for detection and could be a p

54 In addition, a phospho-specific antibody for S800 detects a p38-depende

55 Significantly, using a phospho-specific antibody for Thr-55, we have shown that

56 specific protein kinase substrates for which phospho-specific antibodies have been produced.

57 Immunostaining with phospho-specific antibodies in mammalian cells reveals m

58 We identified proteins cross-reacting to phospho-specific antibodies in response to DNA damage by

59 viously showed, by immunohistochemistry with phospho-specific antibodies, increased phosphorylation (

60 Western blotting analysis using phospho-specific antibodies indicated that recombinant m

61 Furthermore, our phospho-specific antibody microarray analysis indicated

62 sogenic LKB1 knockdown cell line pairs and a phospho-specific antibody microarray, we observed that t

63 acted for JAK-STAT expression levels using a phospho-specific antibody microarray.

64 ed for recognition of the mitotic SPB by the phospho-specific antibody MPM-2.

65 Using site- and phospho-specific antibodies, phosphorylation of MYPT1 Th

66 rylation event in vivo, we generated a novel phospho-specific antibody probe that only recognizes pho

67 the activation state of this pathway using a phospho-specific antibody probe.

68 Using phospho-specific antibodies raised against Ser(111) of e

69 , phosphorylated MT1-MMP is detected using a phospho-specific antibody recognizing a protein kinase C

70 Here, we show that a phospho-specific antibody recognizing the major ATM phos

71 Immunostaining with a phospho-Ser-19/20 phospho-specific antibody revealed that phosphorylated H

72 Phospho-specific antibodies showed that Hippo core kinas

73 Western blot analysis using phospho-specific antibodies showed that phosphorylation

74 Tryptic mass fingerprinting and phospho-specific antibodies showed that Ser466 and Ser48

75 Immunoblot analysis with a phospho-specific antibody showed that the phosphorylatio

76 es hyperphosphorylation, and by generating a phospho-specific antibody targeted to pS222, we identifi

77 ore, we demonstrate by mass spectrometry and phospho-specific antibodies that H2A.X-F is phosphorylat

78 rely on transfer of radioactive phosphate or phospho-specific antibodies that recognize specific subs

79 Using phospho-specific antibodies that recognize the activated

80 ion of this technology is the development of phospho-specific antibodies that specifically recognize

81 re, we show using LC-MS/MS and by generating phospho-specific antibodies that, iteratively with Y221,

82 e widely used monoclonal antibody mAb7a is a phospho-specific antibody that allows the cellular and b

83 lation as reflected by immunoblotting with a phospho-specific antibody that recognizes both kinases.

84 Using a phospho-specific antibody that recognizes NET1 phosphory

85 Using a substrate-directed phospho-specific antibody that recognizes the optimal PK

86 In addition, a phospho-specific antibody that specifically recognizes t

87 Through the use of phospho-specific antibodies, this study also investigate

88 Sensitive phospho-specific antibodies to each of these three sites

89 Subsequently, we used phospho-specific antibodies to examine the regulation of

90 Phospho-specific antibodies to four of these sites estab

91 used (32)P labeling and immunoblotting with phospho-specific antibodies to identify SAMHD1 as a phos

92 We have used phospho-specific antibodies to re-examine the multisite

93 Here, we used phospho-specific antibodies to show that PER2 is phospho

94 In this study, we employed phospho-specific antibodies to show that Ser-247 is a ta

95 tor (IL-11R) activation was determined using phospho-specific antibodies to STAT3.

96 and stress-inducing agents, as determined by phospho-specific antibodies to T81.

97 We developed a Ser-422 phospho-specific antibody to demonstrate that CtBP is ph

98 Using a phospho-specific antibody to detect Ser(12) phosphorylat

99 We used a phospho-specific antibody to determine which PKC isozyme

100 use mass spectrometry and a newly developed phospho-specific antibody to positively identify DAT pho

101 In the present study, we have used a phospho-specific antibody to show that Tyr83 in eNOS is

102 Immunoblotting with phospho-specific antibodies was used to determine the ac

103 Utilizing a phospho-specific antibody we verified that Rpt6 is phosp

104 n immunoprecipitation (ChIP) assays with CTD phospho-specific antibodies, we confirm that RNAP II dis

105 of GSK3, site-specific mutants of p130, and phospho-specific antibodies, we demonstrate here that GS

106 By employing mass spectrometry and phospho-specific antibodies, we demonstrated novel phosp

107 Using mass spectrometry and phospho-specific antibodies, we identified Ser-193 as a

108 Using phospho-specific antibodies, we identified Ser-403 and S

109 Using phospho-specific antibodies, we observed that either adi

110 Using phospho-specific antibodies, we show that olaratumab att

111 Using phospho-specific antibodies, we show that ROCK phosphory

112 By using a Smo phospho-specific antibody, we demonstrate that Smo is di

113 Using a phospho-specific antibody, we observed that ScUGPase-1 w

114 By using a phospho-specific antibody, we show that Abl directly pho

115 Using the PELP1 Ser(991) phospho-specific antibody, we show that PELP1 is hyperph

116 Using a new phospho-specific antibody, we show that YY1 phosphorylat

117 By mass spectrometry and a phospho-specific antibody, we showed that Raptor Thr-908

118 orylation and Western blot assays with novel phospho-specific antibodies were performed.

119 mbrane translocation of individual PKCs, and phospho-specific antibodies were used to determine PKCde

120 XCR4 signaling, tandem mass spectrometry and phospho-specific antibodies were used to identify sites

121 3 phosphorylation is usually monitored using phospho-specific antibodies, which precludes dynamic mea

122 AKT-mTOR pathway function was assessed using phospho-specific antibodies with patient lymphoblasts an

123 rylation of AIP1 at Ser-604 as detected by a phospho-specific antibody, with a similar kinetics to AS